FDA for the second time rejects approval to use Johnson & Johnson blood thinner, Xarelto in treating heart patients and to prevent heart attacks.
New Blood Thinner More Effective Than Warfarin
A new blood thinner developed by Bristol-Myers Squibb and Pfizer Inc was found to be more effective than warfarin in the Phase III trials conducted by the companies.
A new blood thinner developed by Bristol-Myers Squibb and Pfizer Inc was found to be more effective than warfarin in the Phase III trials conducted by the companies.
On tracking down the data from patients who withdrew from the study, the overall results were positive. The drug when used with other regular drugs had the efficiency to reduce the risk of death due to heart disease by 16%.
However, the risk of bleeding increased by nearly four times, which outweighed the efficacy of Xarelto in preventing heart attacks. This has greatly influenced FDA’s decision to reject the blood thinner to treat heart patients.
Big No to Combining Blood Thinners With Acid Reflux Tablets After a Heart Attack
Combo of heartburn drugs and Blood thinners after a heart attack could be lethal as per a recent study.
Combo of heartburn drugs and Blood thinners after a heart attack could be lethal as per a recent study.
Indications of Anticoagulant Therapy or Blood Thinners
Anticoagulants are used to prevent and treat deep vein thrombosis, pulmonary and cerebral embolism, unstable angina, heart attack, atrial fibrillation and disseminated intravascular coagulation.
Anticoagulants are used to prevent and treat deep vein thrombosis, pulmonary and cerebral embolism, unstable angina, heart attack, atrial fibrillation and disseminated intravascular coagulation.
